Current and emerging treatments for amyotrophic lateral sclerosis

BACKGROUND: Amyotrophic lateral sclerosis (ALS) is a relatively rare neurodegenerative disorder of both upper and lower motoneurons. Currently, the management of ALS is essentially symptoms-based, and riluzole, an antiglutamatergic agent, is the only drug for the treatment of ALS approved by the foo...

Descripción completa

Detalles Bibliográficos
Autores principales: Zoccolella, Stefano, Santamato, Andrea, Lamberti, Paolo
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2785861/
https://www.ncbi.nlm.nih.gov/pubmed/19966906

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2785861/
https://www.ncbi.nlm.nih.gov/pubmed/19966906

Ejemplares similares